A cancer diagnosis kit using urine called “Purine Metabolite Assay Kit” by Cubebio Inc. Korea, having sales certificate from Food and Drug Administration of the Philippines in December 2018, is expected to be on sale by WK INT’L MERCHANDISE TRADING in the Phillippine market in late 2019.
This was disclosed yesterday by Charles Hung Soo Park, Chairman of WK INT’L MERCHANDISE TRADING.
Statistics showed that the number of world cancer patients has grown by 33 percent. Notwithstanding rapid growth of world economy and enhanced infrastructure in medical industry, the number of patients has increased steadily. Due to the development of modern medicine, if major cancers are detected early, those cancers can be almost removed with the survival rate for five years over 90 percent. If cancer cannot be conquered in most countries worldwide, the most important thing is “early detection”.
Early detection can significantly reduce the health care costs, the biggest burden in cancer treatment, which is also important for the nation’s health care system, individuals and households, Park said.
For cancer diagnosis, the most widely used method in each country is to check visually, such as a blood test or CT scan. These methods are difficult to operate and expensive, making frequent inspections difficult.
He said Cubebio Inc., a small but strong bio company in Korea, has succeeded in developing “Purine Metabolite Assay Kit” after years of research. “Purine Metabolite Assay Kit” diagnoses cancer by detection and analyzing traces of the body fighting cancer cells through urine sample analysis. The Cubebio’s research team has achieved innovative results in diagnosing cancer by improving the accuracy of the test method after years of research and efforts.
Park said the biggest innovation of the “Purine Metabolite Assay Kit” is that it is simple, fast, safe and inexpensive. This is an in vitro diagnostic kit using urine that can diagnose pancreatic cancer, which has a high mortality rate, as well as liver cancer, lung cancer, colon cancer, and stomach cancer. It can detect from early to terminal cancers, and there are no side effects in the human body by conducting urine tests. It also provides optimal results by allowing multiple inspections and diagnoses at low prices.
He said the second innovation of “Purine Metabolite Assay Kit” is its accuracy, which is the core of the diagnosis kit. The product showed more than 90% accuracy for five major cancers.
The early diagnosis of cancer can have the most economic and social effects, and the “Purine Metabolite Assay Kit” is an innovative product in that sense. Early diagnosis of cancer is expected to contribute greatly to the health of the Filipino people, he added.